Pharmaceutical company AstraZeneca and the European Union have reached an agreement on the supply of anti-Covid vaccines which ends the legal proceedings initiated in the spring by the European Union due to delivery delays, the two parties announced on Friday. .

By the end of the first quarter of 2022, AstraZeneca is committed to delivering an additional total of around 200 million doses to supplement the approximately 100 million already received by the Twenty-Seven as of June 30, 2021, the Commission said. European Union in a press release stressing that the contract signed in August 2020 covered 300 million doses. 

The Anglo-Swedish giant has confirmed this agreement and the end of the ongoing trial before the Belgian courts.

According to the new schedule, the laboratory will deliver 135 million doses of vaccine by the end of the year and 65 million additional doses by the end of March 2022.

The European Union had accused AstraZeneca at the end of May of "flagrant violation" of their contract and demanded 10 euros per dose of anti-Covid vaccine and per day of delay, as part of a legal action linked to delays in deliveries from the laboratory Anglo-Swedish. 

With AFP 

The summary of the week

France 24 invites you to come back to the news that marked the week

I subscribe

Take international news everywhere with you!

Download the France 24 application

google-play-badge_FR